What Addiction Has the Highest and Lowest Recovery Rates?

Key Takeaways

• Opioid use disorder treated with medication-assisted treatment has among the highest treatment retention rates, with 60-70% of patients remaining in buprenorphine treatment at six months (Mattick et al., Cochrane Database, 2014).
• Nicotine dependence has the highest relapse rate among all substances, with approximately 90-95% of unaided quit attempts resulting in relapse within one year (CDC, 2020).
• Methamphetamine addiction currently has no FDA-approved medication, which limits treatment options and contributes to lower treatment retention rates (NIDA, 2024).
• Alcohol use disorder has a large evidence base for treatment, with approximately 36% of treated individuals achieving sustained remission at three years (Dawson et al., Drug and Alcohol Dependence, 2007).
• Opioids are responsible for the highest number of acute overdose deaths, while alcohol causes the most total substance-related deaths when chronic disease is included (CDC WONDER, 2023; WHO, 2024).

Statistics updated quarterly. Last reviewed March 28, 2026.

---

People searching for recovery rates by substance are typically trying to understand the difficulty of overcoming a specific addiction. The honest answer is that comparing recovery rates across substances is methodologically challenging, and simplistic rankings can be misleading. Recovery depends on far more than the substance itself, including treatment availability, social support, co-occurring conditions, and individual neurobiology. That said, there are meaningful differences in treatment outcomes across substance categories, and the research does provide useful, sourced data on how these outcomes vary.

Recovery Rates Vary Significantly by Substance

Why Some Addictions Are Harder to Treat

Several factors explain why treatment outcomes differ across substance categories:

• Availability of FDA-approved medications: Opioid use disorder has three FDA-approved medications (methadone, buprenorphine, naltrexone). Alcohol use disorder has three (naltrexone, acamprosate, disulfiram). Nicotine has several (nicotine replacement therapy, varenicline, bupropion). Methamphetamine and cocaine have none as of 2024 (NIDA, 2024). Substances with pharmacological treatment options tend to show better outcomes because medications improve treatment retention and reduce craving.
• Withdrawal severity: Alcohol and benzodiazepine withdrawal can be medically dangerous, requiring supervised detoxification. Opioid withdrawal, while intensely uncomfortable, is rarely fatal. Stimulant withdrawal is primarily psychological. The nature of withdrawal affects initial treatment engagement (ASAM Clinical Practice Guideline, 2020).
• Speed of dependence development: Some substances produce physical dependence more rapidly than others. Nicotine produces dependence rapidly, with some research suggesting dependent patterns can emerge within weeks of initial regular use (DiFranza et al., Tobacco Control, 2000).
• Social context: Alcohol and nicotine are legal and widely available, making sustained abstinence more challenging from an environmental standpoint. Illicit substances carry criminal justice consequences that may motivate treatment but also create barriers (stigma, employment restrictions, housing barriers).

Factors Beyond the Substance Itself

Individual-level factors often predict recovery outcomes more strongly than the specific substance:

• Co-occurring mental health conditions: The presence of depression, anxiety, PTSD, or other psychiatric conditions significantly affects recovery across all substance categories. According to SAMHSA (2024), approximately 37% of individuals with SUD also have a co-occurring mental health condition.
• Recovery capital: Social support, stable housing, employment, and access to healthcare all influence outcomes regardless of substance type (Laudet and White, Substance Use and Misuse, 2008).
• Number of prior treatment episodes: Contrary to the assumption that repeated treatment failure predicts poor outcomes, research shows that each treatment episode contributes to eventual recovery. A longitudinal study by Dennis et al. (2005) found that the median number of treatment episodes before achieving sustained recovery was three to four.

Substances with Higher Recovery Rates

Alcohol Use Disorder

Alcohol use disorder has the longest treatment research history and a broad evidence base:

• According to the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III), approximately 53.9% of individuals who have ever met criteria for alcohol use disorder eventually achieve sustained remission, either through treatment or natural recovery (Grant et al., JAMA Psychiatry, 2015).
• Among those who receive formal treatment, a 2007 study by Dawson et al. published in Drug and Alcohol Dependence found that approximately 36% achieved sustained abstinent recovery at three years, while an additional 18% achieved non-abstinent recovery (reduced drinking without meeting SUD criteria).
• The combination of behavioral therapy (CBT, motivational enhancement therapy) and medication (naltrexone) produces the best outcomes for alcohol use disorder, according to the COMBINE study, one of the largest alcohol treatment trials ever conducted (Anton et al., JAMA, 2006).

Opioid Use Disorder (with MAT)

When treated with medication-assisted treatment, opioid use disorder shows treatment retention rates that compare favorably to other chronic conditions:

• Approximately 60-70% of patients on buprenorphine remain in treatment at six months, according to a Cochrane review (Mattick et al., 2014).
• Methadone maintenance programs report one-year retention rates of approximately 50-65% (NIDA, 2024).
• MAT reduces all-cause mortality by approximately 50%, making it one of the most effective interventions in addiction medicine (Santo et al., The BMJ, 2021).

However, opioid use disorder without medication has substantially lower recovery rates. A 2019 study in Drug and Alcohol Dependence found that among individuals who completed abstinence-only residential treatment for opioid addiction, approximately 80% experienced relapse within one year (Smyth et al., 2019).

Substances with Lower Recovery Rates

Methamphetamine Addiction

Methamphetamine use disorder presents particular treatment challenges:

• There are currently no FDA-approved medications for methamphetamine addiction, leaving behavioral interventions (particularly contingency management and CBT) as the primary treatment tools (NIDA, 2024).
• Treatment retention rates are lower than for opioid and alcohol use disorders. A 2019 multi-site study found that approximately 35-40% of patients completed a standard outpatient methamphetamine treatment program (Rawson et al., Journal of Substance Abuse Treatment, 2019).
• A promising finding: a 2021 study published in the New England Journal of Medicine found that the combination of injectable naltrexone and oral bupropion reduced methamphetamine use by 13.6 percentage points compared to placebo, the first pharmacological intervention to show significant efficacy in a randomized trial for this population (Trivedi et al., NEJM, 2021). However, this combination has not yet received FDA approval for this indication.
• Long-term outcomes for methamphetamine addiction remain poorly characterized compared to alcohol and opioids, in part because large-scale longitudinal studies have been more limited.

Nicotine Dependence

Nicotine is often excluded from discussions of addiction recovery, but it has the highest relapse rate of any substance:

• Approximately 90-95% of unaided quit attempts result in relapse within one year, according to the CDC (2020).
• Even with evidence-based treatment (nicotine replacement therapy, varenicline, behavioral counseling), one-year quit rates are approximately 20-35% (Cahill et al., Cochrane Database, 2016).
• Nicotine’s high relapse rate is attributed to its wide availability, legal status, strong conditioned associations with daily routines, and rapid cycling of withdrawal (which begins within hours of the last use).
• Despite these challenges, the absolute number of former smokers in the US exceeds 50 million, demonstrating that recovery from nicotine dependence is achievable even if each individual attempt has a lower probability of success (CDC, 2023).

Which Addiction Has the Highest Death Rate

Opioids and Fentanyl Lead in Acute Overdose Deaths

Opioids, particularly illicitly manufactured fentanyl, are responsible for the majority of drug overdose deaths in the United States. According to CDC provisional data (2023):

• Opioids were involved in approximately 81,806 overdose deaths in the 12-month period ending June 2023.
• Synthetic opioids (primarily fentanyl) accounted for approximately 75,000 of those deaths.
• The opioid overdose death rate has increased approximately 700% since 1999, driven by the sequential waves of prescription opioids, heroin, and fentanyl (CDC WONDER, 2023).

In New Jersey, fentanyl was involved in approximately 77% of drug-related deaths in 2022 (NJ Department of Health, 2023).

Alcohol’s Long-Term Mortality Impact

While opioids dominate acute overdose statistics, alcohol causes more total substance-related deaths when chronic health consequences are included:

• The CDC estimates approximately 178,000 annual deaths in the US from excessive alcohol use, including chronic liver disease, alcohol-related cancers, heart disease, and acute causes such as motor vehicle crashes and alcohol poisoning (CDC, 2024).
• The World Health Organization estimated that alcohol was responsible for approximately 5.3% of all deaths globally in 2022 (WHO Global Status Report on Alcohol and Health, 2024).
• A 2022 study published in JAMA Network Open estimated that alcohol was the third leading preventable cause of death in the US, behind tobacco and poor diet/physical inactivity (Esser et al., JAMA Network Open, 2022).

Why Comparing Recovery Rates Requires Caution

Apples-to-Oranges Comparisons

Direct comparison of recovery rates across substances is limited by several methodological issues:

• Different measurement periods and definitions are used across studies of different substances.
• Different populations are studied. Opioid treatment studies often focus on patients entering MAT programs, while alcohol studies may include a broader range of severity.
• Publication bias means that studies with positive results are more likely to be published.
• Evolving drug supply: Recovery rates for opioid use disorder measured before the fentanyl era may not apply to patients using fentanyl-contaminated supplies.

Every Addiction Is Treatable

Regardless of the specific substance, the evidence consistently shows that treatment improves outcomes compared to no treatment. NIDA’s Principles of Drug Addiction Treatment (2018) states that no single treatment is appropriate for everyone, but that effective treatments exist for every major substance use disorder.

The most productive question is not “which addiction is easiest to beat?” but rather “what treatment approach, at what intensity, for what duration, with what supports will produce the best outcome for this specific individual?”

---

This page is part of the Addiction Statistics, Research, and Recovery Data guide on NJ Addiction Centers.

Related resources:

• Drug Addiction Recovery Rates and Long-Term Outcomes
• Rehab Success Rates: What the Data Actually Shows
• Heroin Addiction: Signs, Treatment, and Recovery
• Alcohol Relapse Rates and Prevention